Literature DB >> 10913497

Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction?

L Murphy1, R H Falk.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10913497     DOI： 10.1016/s0002-9149(00)00870-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

1.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 2.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

3.  Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.

Authors:  Satoru Yamamura; Yasuhiro Izumiya; Toshifumi Ishida; Yoshiro Onoue; Yuichi Kimura; Shinsuke Hanatani; Satoshi Araki; Koichiro Fujisue; Daisuke Sueta; Hisanori Kanazawa; Seiji Takashio; Hiroki Usuku; Koichi Sugamura; Kenji Sakamoto; Eiichiro Yamamoto; Megumi Yamamuro; Hisayo Yasuda; Sunao Kojima; Koichi Kaikita; Seiji Hokimoto; Hisao Ogawa; Kenichi Tsujita
Journal:  Heart Vessels       Date:  2016-11-23       Impact factor: 2.037

4.  The atrial uremic cardiomyopathy regression in patients after kidney transplantation - the prospective echocardiographic study.

Authors:  Tomasz Zapolski; Jacek Furmaga; Andrzej P Wysokiński; Anna Wysocka; Sławomir Rudzki; Andrzej Jaroszyński
Journal:  BMC Nephrol       Date:  2019-05-02       Impact factor: 2.388

Review 5.  Cardiac Amyloidosis: Updates in Imaging.

Authors:  Liza Chacko; Raffaele Martone; Francesco Cappelli; Marianna Fontana
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.